Medtronic Bolsters Chronic Disease Arsenal with AI Acquisition and Diabetes Milestone
Medtronic moves to acquire AI-powered coronary analysis firm CathWorks while securing key U.S. coverage for its latest automated insulin delivery system, signaling a dual-front advance in cardiovascular and diabetes care.